The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites.
<h4>Background</h4>Malaria remains a disease of devastating global impact, killing more than 800,000 people every year-the vast majority being children under the age of 5. While effective therapies are available, if malaria is to be eradicated a broader range of small molecule therapeuti...
Guardado en:
Autores principales: | Michael Delves, David Plouffe, Christian Scheurer, Stephan Meister, Sergio Wittlin, Elizabeth A Winzeler, Robert E Sinden, Didier Leroy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eab4562c67984e28b2e94ac3e6fdc00d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites
por: Dorjbal Dorjsuren, et al.
Publicado: (2021) -
Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen
por: Celia Miguel-Blanco, et al.
Publicado: (2017) -
Antimalarial exposure delays Plasmodium falciparum intra-erythrocytic cycle and drives drug transporter genes expression.
por: Maria Isabel Veiga, et al.
Publicado: (2010) -
Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway
por: Gregory M. LaMonte, et al.
Publicado: (2020) -
Wild Anopheles funestus mosquito genotypes are permissive for infection with the rodent malaria parasite, Plasmodium berghei.
por: Jiannong Xu, et al.
Publicado: (2013)